Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy
Introduction: Preterm birth rates and maternal and neonatal mortality remain concerning global health issues, necessitating improved strategies for testing therapeutic compounds during pregnancy. Current 2D or 3D cell models and animal models often fail to provide data that can effectively translate...
Main Authors: | Ananth K. Kammala, Lauren S. Richardson, Enkhtuya Radnaa, Arum Han, Ramkumar Menon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1241815/full |
Similar Items
-
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01) -
Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project
by: Martje Van Neste, et al.
Published: (2023-11-01) -
Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023-12-01) -
Editorial: Exploring Maternal-Fetal Pharmacology Through PBPK Modeling Approaches
by: André Dallmann, et al.
Published: (2022-05-01) -
Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine
by: Liang Zheng, et al.
Published: (2022-01-01)